Daily Mail
Thousands of pancreatic cancer patients have been given hope after scientists revealed they have found a way to stop the disease from spreading.
Imperial College London scientists have pinpointed molecules they call the ‘rabble rouser’ of the cancer, which kills 93 per cent of patients within five years.
Removing these aggressive molecules – called microRNAs – from DNA with gene editing could slow the growth of tumours and make chemotherapy more effective.
Charities today branded the trial on mice ‘crucial’, as scientists work round-the-clock to try and uncover a more effective way to tackle pancreatic cancer.
Figures suggest around 10,000 people are diagnosed with the disease in the UK each year – and survival rates have barely improved since the 1980s.
Pancreatic cancer cells are difficult to stop because they have a hard shell called a stroma, but it is hoped the new breakthrough will be able to stop that from forming.
Weakening cancer cells and slowing their spread could allow chemotherapy to destroy more of the tumours – 80 per cent are diagnosed in their late stages.
Cancer cells without the dangerous microRNA molecules form fewer tumours when injected into mice, the research found.
Human patient samples also showed that survival rates are worse among people who have more of the molecules in their tumours.
Leanne Reynolds, head of research at Pancreatic Cancer UK which funded the study said: “We are incredibly proud to have funded this cutting edge research.”
“It has not only found a crucial new way of slowing down the growth and spread of this tough cancer, but is also paving the way for more effective chemotherapy treatment for patients in the future.”
How the research was carried out
Imperial College researchers published their findings in the Nature Communications journal this week.
They used a gene-editing process called CRISPR – which involves removing sections of DNA – to remove the aggressive microRNAs from cancerous mouse cells.
The cancer cells without the microRNAs do not grow or spread as quickly either in lab conditions or when injected into mice.
Removing the microRNAs could also stop cancer cells forming the tough armour which makes chemotherapy difficult – the stroma – the scientists said.
They also looked at tumour samples from around 100 patients with pancreatic cancer and scanned for levels of the two microRNAs.
Aggressive tumours – which are more likely to prove fatal and spread around the body, contain higher levels of the microRNAs.
Survival rates are also worse among patients with high levels of the molecules.
LATE DIAGNOSIS
Lead researcher Dr Leandro Castellano said: “Sadly by the time people are diagnosed with pancreatic cancer, all too often the disease has spread to other organs.
“And treatment for pancreatic cancer is often not very effective, because the stroma makes it so difficult for treatment to reach the tumour and fight the disease.
“It is, therefore, vital that new ways are discovered to slow down the growth and spread of this disease, and also to improve the effectiveness of treatment.
“Our research was a great success in that we made progress towards tackling both these problems.”
He added that if the research continues to be successful they could move on to a clinical trial ‘in the next few years’.
Pancreatic cancer mainly affects people aged between 50 and 80, and around half of cases are diagnosed in people over 75. A third of cases are linked to smoking.
The pancreas is an organ near the stomach and spleen which produces enzymes for breaking down food – it also makes hormones including insulin.
DANGEROUS CELLS LOOK ‘SPIKY AND ANGRY’
Study author Dr Silvia Ottaviani said a new test for the disease could be based on their ability to identify the most dangerous molecules.
She said: “These molecules act like the ‘rabble-rousers’ in tumour cells – they drive a number of processes that cause cancer cells to become aggressive, and more likely to invade other areas of the body.
“We see this when we look at the cells under a microscope – they become elongated and further apart from each other.
“They are spiky, angry, and they want to go everywhere in the body and cause trouble.
“We are looking at whether these molecules could one day form a type of test allowing doctors to gauge how aggressive a patient’s cancer is, which would help them decide the best treatment options.”
